3-Acryloyloxazolidin-2-one, 95.0%, 1g

7-((2-Hydrazinyl-2-oxoethyl)(methyl)amino)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide, 98%, 100mg

Ethyl 1-methyl-1H-pyrrolo[3,2-b]pyridine-6-carboxylate, 97%, 100mg

tert-Butyl 1-(2-fluorobenzyl)piperidin-4-ylcarbamate, 95.0%, 1g

Methyl (R)-2-amino-4-((tert-butoxycarbonyl)amino)butanoate hydrochloride, 98%, 250mg

Dimetilsolfossido (DMSO), 5L, confezione in plastica., >=99,0%, per sintesi

N,N-Bis(m-tolyl)aniline, 95.0%, 1g

2-AZABICYCLO[3.1.1]HEPTANE-1-CARBOXYLIC ACID HCL, 95.0%, 500mg

4,4,5,5-Tetramethyl-2-(5-methylthiophen-2-yl)-1,3,2-dioxaborolane, 95.0%, 25g

(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL COMPOUND WITH (S)-PROPANE-1,2-DIOL (1:1) HYDRATE, 95%, 250mg

tert-Butyl ((5-bromo-2-methoxypyridin-3-yl)methyl)carbamate, 95%, 1g

(1S,4S)-2,5-Diazabicyclo[2.2.1]heptane Dihydrobromide>98.0%(T)1g

4-octylbenzene-1,3-diol, 5g